Key statistics
On Friday, Treace Medical Concepts Inc (TMCI:NSQ) closed at 1.86, 0.00% above its 52-week low of 1.86, set on Feb 13, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 1.90 |
|---|---|
| High | 1.97 |
| Low | 1.86 |
| Bid | 1.84 |
| Offer | 2.02 |
| Previous close | 1.90 |
| Average volume | 748.35k |
|---|---|
| Shares outstanding | 63.72m |
| Free float | 46.43m |
| P/E (TTM) | -- |
| Market cap | 118.52m USD |
| EPS (TTM) | -0.7947 USD |
Data delayed at least 15 minutes, as of Feb 13 2026 21:00 GMT.
More ▼
- Treace Updates Date of Fourth Quarter and Full-Year 2025 Financial Results Release to February 27, 2026
- Treace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2025 Revenue
- Treace Announces First Surgical Case Utilizing Lapiplasty® Lightning™ Technology
- Treace to Present at 44th Annual J.P. Morgan Healthcare Conference
- Treace Medical Secures Up to $175 Million in Debt Financing
- Treace Announces Participation in Two Upcoming Investor Conferences
- Treace Medical Concepts Reports Third Quarter 2025 Financial Results
- Treace to Report Third Quarter 2025 Financial Results on November 6, 2025
- Treace Highlights New Product Innovations and Updated Positive Clinical Study Data at the 2025 American Orthopaedic Foot & Ankle Society Annual Meeting
- Treace Medical Concepts Reports Second Quarter 2025 Financial Results
More ▼
